Ad26.ZEBOV and MVA-BN-Filo vaccine (Q94747): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 10:09, 16 August 2026
The two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen (Zabdeno and Mvabea) is recommended for preventive use, outside of an outbreak response, in health care and frontline workers in at-risk countries.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_2006409352 |
||
| English | Ad26.ZEBOV and MVA-BN-Filo vaccine |
The two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen (Zabdeno and Mvabea) is recommended for preventive use, outside of an outbreak response, in health care and frontline workers in at-risk countries. |
Statements
CID11:ID_2006409352
0 references
dki-india-ID_2006409352
0 references
Concluído
0 references
15 August 2026
0 references
